GLP-1s help you eat less, but they also change what your body needs to feel good
The Study of Tirzepatide (LY3298176) in Participants With Obesity (SURMOUNT-1) trial found that tirzepatide at 15 mg per week taken over 72 weeks reduced body weight by 20.9% in those with obesity but without diabetes [9]
Two main factors drive this regain: Gastric emptying: Semaglutide slows down gastric emptying, which means food stays in your stomach longer, keeping you fuller after eating
With compounded GLP-1, each patients medication is prepared specifically for them, and drawn up in individual syringes
The needle is short and thindesigned specifically for this type of tissueand the whole process takes seconds
M., Segundo C., Aguilar-Diosdado M